Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 7, 2016
[Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node]Jiahui Huang, Xiaosong Chen, Xiaochun Fei, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Can breast cancer patients with HER2 dual-equivocal tumours be managed as HER2-negative disease?Yiwei Tong, Xiaosong Chen, Xiaochun Fei, et al.
Frontiers in Oncology|October 5, 2020
Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcinoma and Proposal of a Novel Score SystemShuning Ding, Yu Zong, Caijin Lin, et al.
Frontiers in Immunology|July 19, 2024
Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancerZheng Wang, Anqi Li, Yujie Lu, et al.
Frontiers in Pharmacology|May 30, 2023
A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancerRenhong Huang, Han Wang, Jin Hong, et al.
American Journal of Translational Research|November 16, 2020
Long noncoding RNA HOXC-AS3 indicates a poor prognosis and regulates tumorigenesis by binding to YBX1 in breast cancerJun Su, Bo Yu, Chongguo Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 18, 2015
USP2 promotes cell migration and invasion in triple negative breast cancer cell linesQing Qu, Yan Mao, Gang Xiao, et al.
Breast (Edinburgh, Scotland)|November 1, 2025
Development and validation of prognostic model based on distribution and density of CD3<sup>+</sup> and CD8<sup>+</sup> infiltrating lymphocytes in breast cancer: A multicenter cohort studyXu Zhang, Zheng Wang, Yiwei Tong, et al.
Frontiers in Immunology|September 21, 2023
Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancerRenhong Huang, Han Wang, Jin Hong, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 29, 2025
Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancerShuangshuang Lu, Yuliang Zhang, Yiwei Tong, et al.
Pageof 21